India on alert as 21 new cases of JN.1 Covid subvariant reported: Here's what doctors advise
JN.1 subvariant of COVID-19, India is on high alert. This new variant, part of the Omicron family, has spurred a focused response from health authorities as 21 cases have been reported across the country. The World Health Organization has labeled JN.1 as a «variant of interest,» prompting a closer examination of its impact.
The JN.1 variant, a descendant of the BA.2.86 lineage of SARS-CoV-2, is distinct from the Omicron XBB lineages.
It's characterized by over 30 mutations in the spike protein, suggesting potential immune evasion. Despite the rapid spread, health officials have stressed that the overall global public health risk remains low.
Amid this situation, medical professionals emphasize the importance of vigilance without panic. Dr.
Rohit Kumar from Safdarjung Hospital underscores the ever-evolving nature of the virus, urging individuals to remain watchful for symptoms such as sore throat, cough, or difficulty breathing. He particularly highlights the need for those with existing respiratory conditions to take special care.
While the JN.1 variant has been detected in various states, there's no significant clustering of cases, and reported instances have been mild, with patients recovering without complications. Health Secretary Sudhansh Pant assures that while the variant is under intense scrutiny, it isn't an immediate cause for alarm.
Doctors describe initial symptoms of the JN.1 variant, including fever, runny nose, sore throat, headache, and potential gastrointestinal issues, with most symptoms improving within a few days.
However, the CDC warns that distinct symptoms from prior variants remain uncertain.
Experts like Dr. Jacob John and Dr. Neeraj Gupta emphasize that although JN.1 shows higher
